EMI48 is a selective inhibitor targeting the EGFR triple mutant variant. It exhibits enhanced potency compared to its predecessor, EMI1, effectively inhibiting the activity of mutant EGFR. This compound is valuable for research focused on understanding the mechanisms of resistance in cancer therapy and evaluating therapeutic strategies against EGFR-mutant tumors.
EMI48 is a selective inhibitor targeting the EGFR triple mutant variant. It exhibits enhanced potency compared to its predecessor, EMI1, effectively inhibiting the activity of mutant EGFR. This compound is valuable for research focused on understanding the mechanisms of resistance in cancer therapy and evaluating therapeutic strategies against EGFR-mutant tumors.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: